aldosterone has been researched along with Allergy, Drug in 6 studies
Excerpt | Relevance | Reference |
---|---|---|
"The possibility of beta-adrenoreceptor hypersensitivity after abrupt withdrawal of long-term therapy (8-18 months) with the slow-release (SR) formulation of oxprenolol (160-320 mg/day) was assessed in six patients with uncomplicated essential hypertension." | 5.05 | Lack of beta-adrenoreceptor hypersensitivity after abrupt withdrawal of long-term therapy with oxprenolol. ( Amann, FW; Bolli, P; Bühler, FR; Burckhardt, D; Meier, M; Raeder, EA; Rogg, H, 1981) |
"In 30 normotensive individuals and 30 subjects with mild essential hypertension (white men, mean age 26+/-3 years), the responsiveness to angiotensin II was assessed by measuring changes in mean arterial pressure, renal blood flow, glomerular filtration rate and aldosterone secretion in response to i." | 3.70 | Hyper-responsiveness to angiotensin II is related to cardiac structural adaptation in hypertensive subjects. ( Hilgers, K; Klingbeil, AU; Langenfeld, MR; Schäufele, T; Schmieder, RE; Schobel, H, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (66.67) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bolli, P | 1 |
Bühler, FR | 1 |
Raeder, EA | 1 |
Amann, FW | 1 |
Meier, M | 1 |
Rogg, H | 1 |
Burckhardt, D | 1 |
Klingbeil, AU | 1 |
Schobel, H | 1 |
Langenfeld, MR | 1 |
Hilgers, K | 1 |
Schäufele, T | 1 |
Schmieder, RE | 1 |
Karaayvaz, M | 1 |
Caliskaner, Z | 1 |
Baykal, Y | 1 |
Ozanguc, N | 1 |
Porter, GA | 1 |
Bennett, WM | 1 |
Wilson, JW | 1 |
Lansing, AM | 1 |
Irvine, WJ | 1 |
Toft, AD | 1 |
Wilson, KS | 1 |
Fraser, R | 1 |
Wilson, A | 1 |
Young, J | 1 |
Hunter, WM | 1 |
Ismail, AA | 1 |
Burger, PE | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effects of Nebivolol Versus Metoprolol on Blood Flow Responses to Exercise and Angiotensin II in Hypertensive Patients[NCT01502787] | Phase 4 | 46 participants (Actual) | Interventional | 2009-04-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
(NCT01502787)
Timeframe: 12 weeks after initiation of metoprolol
Intervention | mmHg (Mean) |
---|---|
Metoprolol | 114 |
Nebivolol | 113 |
(NCT01502787)
Timeframe: 12 weeks
Intervention | mmHg (Mean) |
---|---|
Initial Treatment With Metoprolol | 101 |
Initial Treatment With Nebivolol | 103 |
(NCT01502787)
Timeframe: 12 weeks after each specified medication
Intervention | ml/min (Mean) |
---|---|
First Intervention Metoprolol: 12 Weeks | 96 |
Second Intervention Nebivolol: 24 Weeks | 105 |
1 review available for aldosterone and Allergy, Drug
Article | Year |
---|---|
Renal consequences of valvular heart disease.
Topics: Aldosterone; Angiocardiography; Contrast Media; Diuresis; Diuretics; Drug Hypersensitivity; Edema; E | 1975 |
1 trial available for aldosterone and Allergy, Drug
Article | Year |
---|---|
Lack of beta-adrenoreceptor hypersensitivity after abrupt withdrawal of long-term therapy with oxprenolol.
Topics: Adrenergic beta-Antagonists; Adult; Aldosterone; Delayed-Action Preparations; Drug Hypersensitivity; | 1981 |
4 other studies available for aldosterone and Allergy, Drug
Article | Year |
---|---|
Hyper-responsiveness to angiotensin II is related to cardiac structural adaptation in hypertensive subjects.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Hype | 1999 |
Renin angiotensin aldosterone system and drug allergies complicated with hypotension.
Topics: Adolescent; Adult; Aldosterone; Anaphylaxis; Angiotensin I; Angiotensin II; Cohort Studies; Drug Hyp | 2000 |
Hypertension in young females receiving anovulatory steroids.
Topics: Adult; Aldosterone; Angiotensin II; Contraceptives, Oral; Drug Hypersensitivity; Female; Humans; Hyp | 1970 |
The effect of synthetic corticotropin analogues on adrenocortical, anterior pituitary and testicular function.
Topics: 11-Hydroxycorticosteroids; Addison Disease; Adrenal Cortex; Adrenal Glands; Adrenocorticotropic Horm | 1974 |